HPV16 ASSOCIATED CERVICAL CANCER

Clinical trials for HPV16 ASSOCIATED CERVICAL CANCER explained in plain language.

Never miss a new study

Get alerted when new HPV16 ASSOCIATED CERVICAL CANCER trials appear

Sign up with your email to follow new studies for HPV16 ASSOCIATED CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New vaccine tested to stop deadly cervical Cancer's return

Prevention Completed

This early-stage study tested the safety of a vaccine called TA-CIN in patients who had recently finished treatment for HPV16 cervical cancer and were currently cancer-free. The goal was to see if the vaccine could safely trigger an immune response to help prevent the cancer from…

Matched conditions: HPV16 ASSOCIATED CERVICAL CANCER

Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Prevention

Last updated Apr 02, 2026 02:11 UTC

HPV16 ASSOCIATED CERVICAL CANCER

Get alerted when new HPV16 ASSOCIATED CERVICAL CANCER trials appear

New vaccine tested to stop deadly cervical Cancer's return